相关实验视频
Updated: Jul 5, 2025

09:52
Trans-Tympanic Drug Delivery for the Treatment of Ototoxicity
Published on: March 16, 2018
9.4K
化纳米脂质体思普拉丁改善了化疗诱导的外围神经病变
Mehrdad Moetamani-Ahmadi1, Amir Mahmoud Ahmadzadeh2, Maryam Alaei1
1Metabolic Syndrome Research Center, Mashhad University of Medical Sciences, Mashhad, Iran; Basic Sciences Research Institute, Mashhad University of Medical Sciences, Mashhad, Iran.
International journal of pharmaceutics
|January 24, 2024
概括
基化纳米脂类体西斯普拉丁通过减轻氧化应激和保护神经细胞,有效地减少了大鼠的化疗诱导的外周神经病变 (CIPN). 这表明,在癌症患者中预防CIPN是一种有前途的治疗策略.
科学领域:
- 纳米医学是一种纳米医学.
- 药理学 药理学是指药理学的学科.
- 毒理学 毒理学 毒理学
背景情况:
- 化疗诱导的周围神经病变 (CIPN) 是西斯治疗的重要副作用.
- 制定减轻CIPN的策略对于改善患者的治疗结果至关重要.
研究的目的:
- 为了评估PEGylated纳米体青 (Cis-PL) 预防CIPN的疗效.
- 在动物模型中评估Cis-PL对氧化应激和神经损伤的影响.
主要方法:
- 合成和鉴定了PEGylated纳米脂质体青 (Cis-PL) 的特征.
- 鼠被用Cis-PL,西斯普拉丁或盐水 (对照) 治疗.
- 使用行为测试,氧化应激标志物,组织病理学和毒性评估来评估CIPN.
主要成果:
- Cis-PL显示出有利的物理化学特性 (颗粒大小,PDI,泽塔潜力,封装效率).
- 与单独使用西斯普拉丁相比,Cis-PL治疗显著降低了神经病变症状.
- Cis-PL减轻了氧化应激,保护了背部根结节神经元,并显示出减少了全身毒性.
结论:
- 基化纳米脂质体西斯丁是一种有前途的方法来管理CIPN.
- 这种配方可能通过减少神经毒性而提供比常规思普拉丁更安全的替代品.
- 需要进一步的临床研究来探索其治疗潜力.
相关概念视频
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
163
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
163
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
203
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
203

